Chiesi Farmaceutici S.p.a.

This study looked at the long-term safety of a drug called pegunigalsidase alfa for adults with Fabry disease, a rare genetic disorder. A total of 97 people who had completed earlier studies received the drug through an IV every two weeks. The main goal was to track any side effe…

This study tested whether using the Foster inhaler for both daily control and quick relief works better than using it only for daily control with a separate rescue inhaler (salbutamol). Over 1,700 adults with not-fully-controlled asthma took part for 48 weeks. The goal was to see…

This study looked at how well a triple-combination inhaler (Trimbow) works for people with COPD in real-world conditions. Over 12 weeks, 362 adults aged 40 and older used the inhaler and reported their symptoms. The goal was to see if the treatment helps control the disease and i…

This study tested a new inhaler (CHF 1535) that combines a steroid and a long-acting bronchodilator against a standard steroid-only inhaler in 542 adults whose asthma was not well controlled with their current medications. The goal was to see if the combination inhaler improved m…

This study tested whether adding an extra inhaler (glycopyrrolate) to a standard steroid inhaler (QVAR) helps adults whose asthma is not well controlled. 98 people took part, and the results showed that the combination improved lung function over a 12-hour period compared to plac…

This study tested whether switching from a standard two-drug inhaler to a newer three-drug extrafine inhaler could improve lung function in people with advanced COPD. Twenty-five participants were followed for several weeks, and their airways were measured using special 3D imagin…

This study tested whether a combination inhaler (steroid plus a long-acting bronchodilator) works better than a steroid-only inhaler for adults with asthma. Over 1,300 participants used either the combo or the steroid-only inhaler for 12 weeks. The main goal was to see if the com…

This study tested whether adding a third medicine (glycopyrrolate) to a standard asthma inhaler (Foster) helps people whose asthma is not well controlled. About 211 adults with uncontrolled asthma took part. The main goal was to see if the new combination improved lung function o…

This study tested a new version of a common asthma inhaler that uses a more environmentally friendly propellant. The goal was to make sure the new inhaler is just as safe and works as well as the current one for people with moderate to severe asthma. Over 800 adults took part in …

This study tested whether adding a third medication to a standard two-drug inhaler could better help people with chronic obstructive pulmonary disease (COPD). Over 3,400 adults with moderate to severe COPD used either the triple or dual inhaler daily for a year. Researchers measu…

This study looked at whether the color of an asthma inhaler (pink or white) affects how people with moderate-to-severe asthma perceive their symptoms. 78 adults who already used a specific inhaler took part. The goal was to see if the device's color could change symptom awareness…

This study followed over 1,000 people with acute coronary syndrome (a serious heart condition) who received the intravenous blood thinner cangrelor during a procedure to open blocked arteries. Researchers tracked how many patients had bleeding events within 30 days after switchin…

This early-stage study tested the safety and how the body handles an experimental inhaled drug called CHF10073. It involved 155 healthy volunteers who received single or multiple doses. The goal was to check for side effects and measure drug levels, not to treat the disease. This…

This study looked at how cyclosporine, a drug that blocks certain transporters, changes the amount of CHF6001 in the blood. Thirty healthy adults took CHF6001 alone and then with cyclosporine to compare drug levels. The goal is to understand potential interactions and guide safe …

This study looked at how much of the asthma drug CHF 6001 enters the blood of teenagers with asthma compared to adults. About 50 people took a single dose of the drug via an inhaler. The goal was to see if the drug behaves similarly in both age groups, which helps doctors decide …